On November 18, AIMday® Diagnostics & Biomarkers in Uppsala brought together academic researchers, industrial representatives and clinicians for discussions on this important and exciting subject.
The AIMday concept is based on questions and topics from the industry that are prepared beforehand. Researchers will then sign up for sessions where they can offer their expertise.
Several SciLifeLab scientists joined the event, among them Tobias Sjöblom from Uppsala university, who participated for the fifth time.
– For me, these meetings are valuable and have led to three collaborations so far; a EU project, a larger project with industry and a smaller collaboration, said Tobias Sjöblom.
Correspondingly, industry representatives expressed their enthusiasm.
– This format is great for identifying potential partners for collaboration in the context of clinical trials, said first-time AIMday contributor Peter Klint, Scientific Advisor Oncology at Bristol-Myers Squibb.
To see the full program and discussed topics, visit: http://aimday.se/diagnostics-biomarkers-2015/
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.